Yahoo
    ASX - Delayed Quote AUD

    Clarity Pharmaceuticals Ltd (CU6.AX)

    1.5700 -0.1000 (-5.99%)
    At close: October 30 at 4:10:11 PM GMT+11
    Loading Chart for CU6.AX
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Registrational Phase III CLARIFY trial: Target number of participants achieved

    Registrational Phase III CLARIFY trial: Target number of participants achieved
    PR Newswire 4d ago
    SECuRE update: recruitment target of the Cohort Expansion Main Group achieved

    SECuRE update: recruitment target of the Cohort Expansion Main Group achieved
    PR Newswire 23d ago
    Why Clarity Pharmaceuticals (ASX:CU6) Is Up 11.7% After Investor Focus On Copper Cancer Theranostics

    Why Clarity Pharmaceuticals (ASX:CU6) Is Up 11.7% After Investor Focus On Copper Cancer Theranostics
    Simply Wall St. 3mo ago
    Clarity signs a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with Nucleus RadioPharma

    Clarity signs a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with Nucleus RadioPharma
    PR Newswire 6mo ago
    Co-PSMA data published in the European Urology journal

    Co-PSMA data published in the European Urology journal
    PR Newswire 6mo ago
    3 ASX Growth Stocks With Insider Ownership Expecting Up To 50% ROE

    3 ASX Growth Stocks With Insider Ownership Expecting Up To 50% ROE
    Simply Wall St. 5mo ago
    Clarity Pharmaceuticals Announces SECuRE Trial Update on 8 GBq 67Cu-SAR-bisPSMA dose level with two additional complete responses

    Clarity Pharmaceuticals Announces SECuRE Trial Update on 8 GBq 67Cu-SAR-bisPSMA dose level with two additional complete responses
    PR Newswire 2mo ago
    ASX Growth Leaders With Insider Stakes May 2026

    ASX Growth Leaders With Insider Stakes May 2026
    Simply Wall St. 5mo ago
    ASX Growth Companies With High Insider Ownership In April 2026

    ASX Growth Companies With High Insider Ownership In April 2026
    Simply Wall St. 6mo ago
    ASX Growth Companies With Significant Insider Ownership

    ASX Growth Companies With Significant Insider Ownership
    Simply Wall St. 5mo ago
    Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight

    Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight
    PR Newswire 7mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: